# The Cooper Companies, Inc. – Consensus ‘buy’ rating and 9.1% Upside Potential

- Link: https://www.directorstalkinterviews.com/the-cooper-companies-inc.consensus-buy-rating-and-9.1-upside-potential/4121126356
- Published: 2023-08-30T11:35:53+01:00
- Author: Charlotte Edwards

**The Cooper Companies, Inc.** which can be found using ticker (COO) now have 13
analysts in total covering the stock. The consensus rating is pointing to ‘buy’.
The target price High/Low ranges between 440 and 345 and has a mean target at $407.38.
Now with the previous closing price of $373.36 this is indicating there is a potential
upside of 9.1%. The day 50 moving average is $381.38 and the 200 moving average 
now moves to $357.04. The company has a market capitalization of 18.72B. The stock
price for the company is currently 378.11 USD

 The potential market cap would be $20,425,116,940 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 64.97, revenue per share of 69.52
and a 2.62% return on assets.

The Cooper Companies, Inc. is a global medical device company. The Company operates
through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged
in developing, manufacturing and marketing a range of products for contact lens 
wearers, featuring advanced materials and optics. CooperVision segment designs its
products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular
dryness and eye fatigue, with a broad collection of spherical, toric and multifocal
contact lenses. CooperSurgical segment focus on advancing the health of women, babies
and families through a diversified portfolio of products and services focusing on
women’s health and fertility. CooperSurgical segment supplies the family health 
care market with a diversified portfolio of products and services. Its office and
surgical offerings include products that facilitate surgical and non-surgical procedures
that are commonly performed primarily by obstetricians and gynecologists.

Share on: